Cumin

Cumin (Cuminum cyminum L.)

1. Identity and Botanical Description

Cumin (Cuminum cyminum L.) is a flowering plant in the family Apiaceae, native to the Irano-Turanian Region. It is an annual, herbaceous, spice glycophyte that has various applications as a food and flavoring additive and therapeutic agent. It is a relatively small plant that typically grows to a height of 30–50 centimetres (12–20 inches).

Synonyms include Cuminum odorum Salisb., Cuminia cyminum J.F. Gmel., Cuminum hispanicum Bunge, and Ligusticum cuminum (L.) Crantz. Despite being commonly known as a spice, the cumin "seed" is technically a fruit derived from the small flowering plant Cuminum cyminum, which belongs to the same family as dill and parsley. Cumin consists of the dried, ripe fruit of Cuminum cyminum L. (Apiaceae); the schizocarps are about 6 mm long, attached to short pedicels, and separated into mericarps.

The plant has been cultivated for thousands of years, and today India and Iran are the biggest producers; the herb is also cultivated in China, Indonesia, Sri Lanka, Pakistan, Turkey, Morocco, Egypt, Sicily, Malta, Cyprus, the southern parts of Russia, and in Central and South America.

Common Names and Disambiguation

Cumin should not be confused with sweet cumin, which is a common name for anise (Pimpinella anisum). Black cumin (Bunium persicum) has smaller and sweeter seeds than C. cyminum but is not commercially important. Nigella sativa (a separate black cumin species) is not related to cumin. These distinct species are frequently conflated in lay literature; research findings concerning Nigella sativa do not necessarily apply to Cuminum cyminum.

Common Preparations and Forms

• The seeds of C. cyminum are used in the cuisines of many different cultures, in both whole and ground forms.
• Cumin and value-added products are used in food flavoring and perfumery. Cumin contains volatile oil (3–4%), with cuminaldehyde, the major active principle, present to an extent of 45–50%.
• Value-added products include cumin oil and oleoresin for export. Cumin powder forms the main component of many spice mixes and curry powders.
• It is widely used in the beverage, food, liquor, medicine, perfume, and toiletry industries.

2. Traditional and Historical Use

Ancient Egypt and the Near East

In the Egyptian Ebers Papyrus (written around 1550 BC), cumin is described as an ingredient in several Egyptian medicines, and the seeds have been found inside some of the Egyptian pyramids. Cumin was used by the ancient Egyptians, who called it tpnn; ancient Egyptian king Ramesses III offered gifts of cumin to the god Ra at Heliopolis. The ancient Egyptians used cumin to treat gastro-intestinal disease, to expel intestinal parasites, and cumin was included in different medicinal recipes for mouth rinses, suppositories, and ear instillations.

Mesopotamia

Cumin's presence in medical texts from Mesopotamia points to its applications beyond gastronomy, including medicine and trade. From feasts in northern Iraq around the 9th century to ancient Greece and the Roman Empire, cumin has been documented to be used widely as a flavoring and natural medicine to cure or ease a variety of ailments such as digestive problems.

Ancient Greece and Rome

Cumin was a significant spice for the Minoans in ancient Crete. Ideograms for cumin appear in Linear A archive tablets documenting Minoan palace stores during the Late Minoan period. The ancient Greeks kept cumin at the dining table in its own container, much as pepper is frequently kept today. Ancient Greek physicians like Hippocrates noted cumin's carminative effects, using it to treat menstrual spasms and breath malodor, while Roman author Pliny the Elder recommended cumin seeds for their diuretic and antiseptic properties. Among Europe's oldest cultures, cumin was highly valued as a spice and was used as a pepper substitute in ancient Rome.

Medieval Europe

From its origins in Mesopotamia, cumin moved through Europe as a spice, a medicine, and even as a currency in Medieval England, where it was used to pay rent. The herb has been cultivated in Spain since the 11th century.

Ayurvedic Medicine (India)

In Ayurveda, cumin is considered a daily-use spice that supports digestion, metabolism, and overall vitality. With its pungent, hot, dry, and bitter qualities, cumin kindles digestive fire (agni), supports ojas (vital essence), and helps pacify excess vata and kapha doshas. In classical Ayurveda, cumin was rarely used alone; it usually appeared in digestive blends like Trikatu (with pepper and ginger) and in herbal decoctions for colon and urinary health. Over centuries, cumin's role shifted from a pure digestive stimulant to a multi-purpose tonic, featured in choorna (powder), kwath (decoction), and even medicated ghee recipes.

Unani and Persian Medicine

During the medieval period, Persian scholars integrated cumin in Unani medicine for liver support, and spice traders spread its use to Europe and North Africa. While classical Ayurveda leans on cumin's warming virya (potency) to alleviate kapha stagnation, Unani medicine integrated it alongside fennel for "strengthening the stomach."

Traditional Medicinal Purposes Across Cultures

Cumin has traditionally been used for its anti-inflammatory, diuretic, carminative, and antispasmodic effects. It has also been used as an aid for treating dyspepsia, jaundice, diarrhea, flatulence, and indigestion. Traditionally, Cuminum cyminum has been used for the treatment of indigestion and hypertension. Cumin seed is listed in Biblical texts in both the Old and New Testaments.

Spread via Trade

Cumin's popularity grew due to extensive trade networks connecting various regions. It traveled along the Silk Road and other ancient trading routes, helping spread its use from its original regions to new areas in Asia, Africa, and eventually the Americas. The Columbian Exchange, instigated in the late 15th century, initiated the transfer of many food products from the Old World to the New, and cumin was one of the spices that made the voyage and embedded itself into a variety of cuisines in the Americas.

3. Key Constituents and Active Compounds

Proximate and Nutritional Composition

Cumin fruits mainly contain cellulose, fixed oil content (about 10%), mineral elements, protein, sugar, and volatile oils (1.5%), as well as appreciable amounts of phenolic compounds. It contains essential minerals including iron, magnesium, calcium, potassium, zinc, phosphorus, selenium, copper, and manganese, along with B vitamins such as folate, thiamine, niacin, riboflavin, and pyridoxine. Vitamins A, C, E, and K are also present in smaller amounts.

Volatile Oil Fraction

Cumin contains volatile oil (3–4%); cuminaldehyde is the major active principle, present to an extent of 45–50%. A total of 102 compounds have been identified in cumin. Of these, 62 were found in the aqueous extract, including 10 flavonoids, 7 phenylpropanoids, 5 terpenoids, 4 alkaloids, 7 organic acids, 8 fatty acids, 8 amino acids, 2 glycosides, and 10 other components. In addition, 40 compounds were characterized in the volatile oil, accounting for 98.70% of the total volatile content.

The major volatile components identified by GC-MS analyses include:

• Cuminaldehyde (19.9–64.31%), p-cymene (6.1–47.08%), cuminal (36.31%), and α-pinene (0.5–29.2%).
• γ-Terpinene (6.49–27%), beta-pinene (11.13–11.59%), 2-caren-10-al (7.93–11.20%), cumic alcohol (2.8–16.92%), and geraniol (0.02–2.39%).

The quality and quantity of compounds commonly identified in cumin vary across the different parts of the plant, such as the leaves, shoots, roots, and flowers. Both the shoots and flowers have relatively similar terpene compounds, though their concentrations are higher in the flowers. Furthermore, α-pinene and β-pinene were not found in the roots, and α-phellandrene was notably the only detected terpenoid compound in the leaves, while the flowers had the highest concentration of α-pinene.

Non-Volatile Phenolic and Other Constituents

Additionally, cumin is rich in plant antioxidants — flavonoids, polyphenols, alkaloids, terpenes, and tannins — which help neutralize free radicals and protect cells from oxidative stress. Alcohol and water extracts of cumin are reported to possess nutraceutical properties including antiallergic, antioxidant, anti-platelet aggregation, and hypoglycemic effects.

4. Established and Proposed Mechanisms of Action

Cuminaldehyde and Anti-inflammatory Signaling

Volatile constituents identified in essential oil by GC-MS show that cuminaldehyde is the most abundant constituent (48.8%). Cumin oil has been shown to exert anti-inflammatory effects in LPS-stimulated RAW 264.7 cells through inhibiting NF-κB and mitogen-activated protein kinases, suggesting its potential as an anti-inflammatory agent. This evidence is based on in vitro (cell culture) data and has not been confirmed in human trials.

Antifungal Membrane Disruption

The chemical components of cumin essential oil (cuminaldehyde 44.53%, p-cymene 12.14%, β-pinene 10.47%, and γ-terpinene 8.40%) were found to inhibit the growth of pathogenic fungi in vitro. SEM and TEM images demonstrated that cuminaldehyde and cumin essential oil increased cell permeability and disrupted membrane integrity. Again, this is preclinical (in vitro) evidence.

Antioxidant Activity

The interactions between carvacrol and other monoterpenes in cumin, such as cuminaldehyde, α-thujene, γ-terpinene, 1,8-cineole, thymol, and p-cymene, result in synergistic effects that likely explain the observed increase in antioxidant activity.

Digestive Enzyme Stimulation

Cumin (Cuminum cyminum) has a long track record for easing digestive problems. Modern studies suggest it boosts digestive enzyme activity, speeding the breakdown of food. It also encourages the release of bile from the liver, which helps digest fats and absorb nutrients.

Antiplatelet Effects

Alcohol and water extracts of cumin are reported to possess anti-platelet aggregation activity. The in vivo relevance of this activity in humans requires further investigation through dedicated clinical trials.

5. Scientific Evidence by Area of Use

Important note on overall evidence quality: Although cumin is used in traditional medicine, there is no high-quality evidence that it is safe or effective as a therapeutic agent. Most human trials to date are small, have been conducted primarily in Iran, and the results are often inconsistent. Where evidence is stronger, it is noted; where it remains preliminary, that is stated explicitly.

5.1 Gastrointestinal Health and Irritable Bowel Syndrome (IBS)

Approximately 28% of patients with functional GI disorders suffer from IBS, and they compose 20–50% of patients who are referred to gastroenterologists. A 2013 clinical trial found that patients with irritable bowel syndrome (IBS) who took cumin extract twice daily experienced significant relief from abdominal cramps, bloating, nausea, bowel irregularity, and mucus discharge within four weeks. A clinical study published in the Middle East Journal of Digestive Diseases examined the effects of cumin extract on IBS patients; after four weeks of supplementation, participants reported significant reductions in abdominal pain, bloating, and irregular bowel movements. These findings are consistent with cumin's known carminative and antispasmodic properties but are based on small case series and limited trials; further larger RCTs are needed to confirm these results.

5.2 Body Weight and Anthropometric Parameters

Several RCTs have examined cumin's effects on body composition:

• Cumin powder at 3 g/day (1.5 g twice daily) was used to evaluate effects on lipid profiles and body composition in a study of women who were overweight/obese (Zare 2014). Essential oil of C. cyminum administered at 300 mg/day for 8 weeks was also used to evaluate effects on weight loss and metabolic profiles in Iranian adults who were overweight (Taghizadeh 2015).
• One study revealed that taking 300 mg C. cyminum for eight weeks resulted in significant decreases in weight, body mass index (BMI), insulin, and homeostatic measures.
• An expression of concern has been published for the Taghizadeh 2015 trial, which is an important caveat that reduces confidence in those specific findings.
• A systematic review and meta-analysis incorporating data from eight included studies indicated that CC supplementation can lower BMI (WMD = −0.88 kg/m²; 95% CI: −1.58, −0.18; p = .023) and total cholesterol (TC) (WMD = −3.96 mg/dl; 95% CI: −6.51, −1.04; p = .008).

Overall, while pooled data suggest modest BMI reductions, the individual trials are small, conducted largely in a single country (Iran), and at least one key trial has been flagged with an expression of concern. Evidence at this stage is preliminary.

5.3 Glycemic Control and Diabetes

A systematic review and meta-analysis aimed to examine the effect of cumin supplementation on markers of glycemic control in adults. A comprehensive literature search was conducted from inception to November 2020 across PubMed, Scopus, Web of Sciences, and Cochrane electronic databases; studies comparing cumin with placebo on fasting blood sugar (FBS), serum insulin, and HOMA-IR index were eligible.

A total of eight RCT studies involving 552 participants were included. The results of the meta-analysis suggest that cumin supplementation did not significantly alter serum FBS (WMD: −17.77 mg/dl; 95% CI: −36.42 to 0.87, p = .06) or insulin level.

A separate 2025 meta-analysis included a total of nine studies published between 2013 and 2020, with intervention durations ranging from 8 to 24 weeks. The results indicated that cumin supplementation significantly affected several components of metabolic syndrome, including a significant reduction in fasting blood sugar. Of the nine RCTs included, five were of high quality. Using the GRADE approach, FBS, HDL-C, and TG outcomes were rated as low quality evidence, and waist circumference was rated as moderate quality evidence.

Compared with orlistat and placebo, cumin supplementation led to improvements in serum insulin levels, beta-cell function, and insulin sensitivity but not in fasting plasma glucose or insulin resistance measures (Taghizadeh 2015). As noted above, this trial carries an expression of concern.

In summary: meta-analytic evidence on glycemic control is inconsistent and of low to moderate quality; results across individual trials conflict, and the evidence base is limited by small sample sizes, single-country concentration, and methodological concerns.

5.4 Lipid Profile

A systematic review and meta-analysis of randomized controlled clinical trials evaluated the efficacy of Cuminum cyminum supplementation on lipid profile and anthropometric parameters, with databases systematically searched until May 2021. Data from eight included studies indicated that CC supplementation can lower BMI (WMD = −0.88 kg/m²; 95% CI: −1.58, −0.18; p = .023) and total cholesterol (TC) (WMD = −3.96 mg/dl; 95% CI: −6.51, −1.04; p = .008). Evidence also showed that cumin may not only reduce anthropometric indices including weight, BMI, and waist circumference, but that supplementation improved cholesterol, triglyceride, LDL-C, and HDL-C. These effects are statistically significant in some pooled analyses but are modest in absolute magnitude, and the evidence is graded low to moderate.

5.5 Metabolic Syndrome Components

Cumin (Cuminum cyminum L.) is recognized for its anti-diabetic, anti-inflammatory, and antioxidant properties, which may influence components of metabolic syndrome (MetS) in adults with metabolic disorders. However, previous studies have reported inconclusive and sometimes conflicting results. Administered cumin dosages in studies were between 0.025 g/day and 2 g/day in the form of oil or powder.

5.6 Antioxidant Effects

Compared with placebo or orlistat, cumin supplementation provided no effect on oxidative stress as measured by total plasma glutathione (Taghizadeh 2015). Antioxidant activity of cumin has been more consistently demonstrated in laboratory assays (in vitro) than in human clinical trials, where outcomes on oxidative stress markers have been mixed.

5.7 Antimicrobial Activity

Cumin possesses antibacterial and antifungal properties, making it effective in combating skin infections and other microbial ailments according to laboratory studies. A 2008 study investigated the antibacterial mechanism of carvacrol and thymol, two components in cumin seeds, against E. coli. The study included a 200-milligram treatment and demonstrated that carvacrol and thymol had the desired antimicrobial effect against the bacteria. The clinical relevance of these in vitro antimicrobial findings for human infections has not been established through adequately powered human trials.

5.8 Herb–Drug Interactions: Antidiabetic Agents

Animal-model acute toxicity studies showed the extract to be safe up to a dose of 2 g/kg. The extract alone, and in combination with glyburide (at half-dose), significantly lowered elevated glucose (by more than 45% from baseline, without producing hypoglycemia), and other lipid and renal parameters. HPLC analysis revealed differing pharmacokinetics of glyburide in groups treated with the 5 mg/kg dose and 2.5 mg/kg + 600 mg/kg extract, indicating a pharmacokinetic interaction. This is animal-model data; human pharmacokinetic studies with glyburide and cumin are currently absent from the literature.

5.9 Oncology: Preclinical Chemopreventive Data

In mice, cumin seeds inhibited the induction of gastric squamous cell carcinomas. Cumin also demonstrated a protective effect against induced colonic cancer in rats. Decreased beta-glucuronidase and mucinase activity was evident, and the rats had fewer papillae, no infiltration into the submucosa, and fewer morphological changes. Cumin seeds were not carcinogenic when tested by the reverse mutation Salmonella typhimurium (TA100) test, but demonstrated very weak oxidative mutagenicity with strain TA102. All chemopreventive evidence is at the animal/in vitro stage; no human clinical trials have confirmed anticancer effects for Cuminum cyminum.

6. Body Systems and Health Areas of Association

• Gastrointestinal system: Traditional uses include carminative, antispasmodic, and anti-dyspepsia effects; clinical use for flatulence, indigestion, diarrhea, and jaundice.
• Metabolic/endocrine system: Recognized for anti-diabetic and antioxidant properties that may influence components of metabolic syndrome in adults with metabolic disorders.
• Cardiovascular system: Cardioprotective and anti-inflammatory effects have been explored in preclinical research.
• Immune and inflammatory system: Cumin oil exerts anti-inflammatory effects through inhibiting NF-κB and mitogen-activated protein kinases, suggesting its potential as an anti-inflammatory agent, based on cell studies.
• Antimicrobial: The medicinal and health potential of cumin is attributed in the preclinical literature to its antioxidant, antibacterial, antifungal, anti-inflammatory, and antidiabetic properties.
• Lactation: Cumin has been used as a galactogogue in India and Türkiye, with some literature support, including as part of an herbal mixture.

7. Dosage Forms and Dosages Reported in Studies

The following dosages have been specifically reported in the clinical and research literature. They are presented for informational purposes and are not recommendations.

• Cumin powder at 3 g/day (1.5 g twice daily, with lunch and dinner) was used to evaluate effects on lipid profiles and body composition in overweight/obese women (Zare 2014).
• Essential oil of C. cyminum was administered at 300 mg/day for 8 weeks to evaluate effects on weight loss and metabolic profiles in Iranian adults who were overweight (Taghizadeh 2015).
• Administered cumin dosages across included RCTs were between 0.025 g/day and 2 g/day in the form of oil or powder.
• Intervention durations in the meta-analytic studies ranged from 8 to 24 weeks.
• Effects of cumin supplementation on metabolic profiles in patients with metabolic syndrome were investigated in an RCT with N = 56 participants aged 18 to 60 years.
• One randomized double-blind placebo-controlled trial was conducted on 72 subjects with overweight aged 18–50 years; Group A received high-dose Cuminum cyminum plus lime capsules (75 mg each), providing data on a lower end of supplemental dosing.

8. Safety Considerations and Interactions

Regulatory Status

Cumin is "generally recognized as safe" (GRAS) as a spice and flavoring by the U.S. Food and Drug Administration.

General Tolerability

Cumin (Cuminum cyminum) is widely used as a spice and in traditional medicine, and is generally considered safe when consumed in typical dietary amounts. However, studies have reported some potential adverse effects, particularly at higher doses or in concentrated forms such as essential oils. In human clinical trials, cumin supplementation did not result in significant adverse effects, and no serious side effects or significant changes in liver or kidney function were reported.

Phototoxicity

Cumin is generally well tolerated, but occasional phototoxic skin reactions have been reported after contact with the oil. Cumin essential oil may have phototoxic effects because it contains cuminaldehyde. Direct contact with cumin essential oil may cause skin irritation or photosensitivity in some individuals; essential oils should be properly diluted and a patch test performed before applying to larger areas of skin.

Allergic Reactions and Cross-Reactivity

Those allergic to cumin or related herbs should avoid cumin. People allergic to plants in the Apiaceae family (such as celery, parsley, or fennel) may also be allergic to cumin.

Gastrointestinal Effects

Cumin might cause an upset stomach in some people. Cumin is a potent carminative, meaning it relaxes the smooth muscles of the digestive tract. This includes the lower esophageal sphincter (LES), the valve that separates the stomach from the esophagus. Relaxation of the LES can allow stomach acid to reflux back into the esophagus, causing or worsening heartburn and symptoms of gastroesophageal reflux disease (GERD).

Essential Oil Toxicity at High Doses

Cumin is not toxic when consumed as a spice or seeds powder supplement and is considered a safe food. However, cumin contains medicinal substances which, consumed in excess, can have toxic effects. The only adverse effects may occur by ingesting large quantities of cumin seeds or, most likely, due to the use of its essential oil. Cumin contains terpenoids which may have neurotoxic effects; the essential oil is toxic at high concentrations and can cause seizures and spasms.

Drug Interactions

Cumin may lower blood sugar and slow blood clotting in medicinal doses, warranting caution in certain individuals.

• Anticoagulants: Cumin may enhance the effects of anticoagulant medications, increasing the risk of bleeding.
• Antidiabetic medications: Cumin may lower blood sugar levels, potentially necessitating adjustments in diabetic medications. HPLC analysis in animal research revealed differing pharmacokinetics of glyburide when combined with cumin extract, indicating a pharmacokinetic interaction that may require monitoring.

Pregnancy and Lactation

Information regarding safety and efficacy in pregnancy and lactation is lacking. While culinary amounts of cumin are generally considered safe during pregnancy, medicinal or supplement doses should be avoided. Traditional medicine has sometimes used high doses of cumin to stimulate menstruation, which could be dangerous during pregnancy. No data exist on the excretion of any components of cumin into breastmilk or on the safety and efficacy of cumin in nursing mothers or infants.

Gallbladder Disease

Because cumin stimulates bile flow, it may aggravate gallbladder pain in individuals with gallstones.

Contaminants

Some cumin sources, particularly from certain regions, may contain heavy metals like lead. Purchasing cumin from reputable sources that test for contaminants is prudent.

Animal Toxicology Data

In animal studies, oral administration of cumin essential oil led to changes in blood parameters, including a decrease in white blood cell count and increases in hemoglobin, hematocrit, and platelet counts, though no severe toxicity was observed over a 30-day period. Acute toxicity studies showed the extract to be safe up to a dose of 2 g/kg body weight in the rodent model studied.

References

• Bai Y, et al. "The Chemical Composition of Cumin (Cuminum cyminum L.) Analyzed by UPLC-Q-Orbitrap MS and GC-MS." Natural Product Communications, 2025.
• Baş M, et al. "Chemical composition, biological activities, uses, nutritional and mineral contents of cumin (Cuminum cyminum)." ScienceDirect, 2024.
• Zhong J, et al. "Chemical Constituents of the Essential oil from Cuminum cyminum L. and Its Antifungal Activity against Panax notoginseng Pathogens." PubMed, 2021.
• Srinivasan K. "Cumin (Cuminum cyminum) and black cumin (Nigella sativa) seeds: traditional uses, chemical constituents, and nutraceutical effects." Food Quality and Safety, 2018.
• Atalay S, et al. "Cumin (Cuminum cyminum L.): A review of its ethnopharmacology, phytochemistry." Biomedical Research and Therapy, 2020.
• Johri RK. "Chemistry, technology, and nutraceutical functions of cumin (Cuminum cyminum L): an overview." PubMed, 2013.
• ScienceDirect Topics: Cuminum cyminum overview.
• Wikipedia: Cumin.
• Ghorbani H, et al. "The effect of cumin (Cuminum cyminum L.) supplementation on glycemic indices: A systematic review and meta-analysis of randomized controlled trials." Phytotherapy Research, 2021.
• Mohseni M, et al. "Efficacy of Cuminum cyminum supplementation on lipid profile and anthropometric parameters: A systematic review and meta-analysis of randomized controlled clinical trials." Phytotherapy Research, 2022.
• Liu M, et al. "Potential benefits of Cuminum cyminum L supplementation on components of metabolic syndrome in adults with metabolic disorders: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials." Frontiers in Nutrition, 2025/2026.
• Khanam S, et al. "Pharmacodynamic interaction of cumin seeds (Cuminum cyminum L.) with glyburide in diabetes." PubMed, 2019.
• Agah S, et al. "Cumin Extract for Symptom Control in Patients with Irritable Bowel Syndrome: A Case Series." PMC, 2014.
• Taghizadeh M, et al. "The Effect of Cumin cyminum L. Plus Lime Administration on Weight Loss and Metabolic Status in Overweight Subjects." PMC, 2016.
• Taghizadeh M, et al. "Effect of the Cumin cyminum L. Intake on Weight Loss, Metabolic Profiles and Biomarkers of Oxidative Stress in Overweight Subjects." Annals of Nutrition and Metabolism, 2015. (Expression of concern published.)
• LactMed: Cumin — Drugs and Lactation Database. National Library of Medicine / NCBI Bookshelf.
• Drugs.com Natural Product: Cumin (Cuminum cyminum) — Uses, Benefits & Dosage.
• UC Davis Nutritional Geography: Cumin.
• Nature Scientific Reports: "Enhancing antioxidant and antibacterial activities of Cuminum cyminum." 2025.
• ScienceAlert: "5 Common Herbs And Spices With Digestive Benefits, Backed by Science." 2025.